Novo Nordisk A/S (NYSE:NVO) achieved significant growth in 2022, primarily fueled by its semaglutide franchise for type 2 diabetes and obesity. The solid sales performance of Ozempic, Rybelsus, and ...

If you're a new investor and tend to gravitate toward growth stocks, there are plenty of compelling buys to consider in the ...

For the second consecutive year, the “Most Innovative Product®” award goes to the BioNTech/Pfizer Covid-19 vaccine Comirnaty®. The biotechnology company was further delighted to receive the award “The ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to see the 10 Largest Pharmaceutical Companies in ...

The global pharmaceutical industry tops $1.2 trillion in sales each year. This huge sector improves the quality of life for many people while creating attractive opportunities for long-term investors.

BOSTON--(BUSINESS WIRE)--ZoomRx is pleased to announce that multiple top 20 pharmaceutical companies have renewed their Promotional Effectiveness Tracking studies with ZoomRx. As a data-driven ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The global pharmaceutical market reached a total value of US$1.38 trillion in 2024, according to Research and Markets, up significantly from the US$888 billion seen just over a decade earlier in 2010.